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Survival of antigen-specific CD81 T cells in peripheral lymphoid organs during viral
infection is known to be dependent predominantly on IL-7 and IL-15. However, little is
known about a possible influence of tissue environmental factors on this process. To
address this question, we studied survival of memory antigen-specific CD81 T cells in the
small intestine. Here, we show that 2 months after vaccinia virus infection, B8R20–27/H2-K
b
tetramer1 CD81 T cells in the small intestinal intraepithelial (SI-IEL) layer are found in
mice deficient in IL-15 expression. Moreover, SI-IEL and lamina propria lymphocytes do
not express the receptor for IL-7 (IL-7Ra/CD127). In addition, after in vitro stimulation with
B8R20–27 peptide, SI-IEL cells do not produce high amounts of IFN-c neither at 5 days nor at
2 months postinfection (p.i.). Importantly, the lack of IL-15 was found to shape the func-
tional activity of antigen-specific CD81 T cells, by narrowing the CTL avidity repertoire.
Taken together, these results reveal that survival factors, as well as the functional activity,
of antigen-specific CD81 T cells in the SI-IEL compartments may markedly differ from
their counterparts in peripheral lymphoid tissues.
Introduction
Gastrointestinal mucosa represents a major site of entry as well as
initial replication for many viral and bacterial pathogens
(including HIV). Massive depletion of CD41CCR51 memory
T cells occurs in the mucosal tissues within the first 2weeks of
HIV-1 infection [1, 2]. In connection with this, vaccines providing
protection against gastrointestinal infectious diseases must be
able to induce long-term mucosal immune responses [3–9].
Previously, we demonstrated that long-lasting protection against
mucosal viral transmission could be accomplished by CD81 CTLs
that must be present at the mucosal site of antigen exposure,
although some mucosal memory CTLs may be induced even after
systemic vaccination [10–16]. This protective effect was ablated
when CD81 cells were depleted in vivo, and required that CTLs
were present in the gut mucosa, whereas splenic CTLs alone were
unable to protect against mucosal viral challenge [10]. Thus,
unless Abs are able to completely prevent viral entry, induction of
local long-lasting mucosal CD81 CTLs in the gut should be
considered essential to design a protective mucosal vaccine.
The maintenance of antigen-specific CD81 T cells, their
homeostatic proliferation and survival during the memory phase of
immune responses are known to be predominantly dependent on
IL-15 and IL-7, respectively [17–26]. Other cytokines elicited by
infectious (or tumor) antigens may work during the primary
response as endogenous adjuvants, and could contribute to the
survival of long-lived memory CD81 T cells [27–30]. Based on
proliferative potential, cytokine production, and surface pheno-
type, memory CD81 T cells can be divided into effector memory
(EM) and central memory (CM) cells [31, 32]. One approach to
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discriminate between these two subsets is based on the detection
of surface IL-7Ra/CD127 and CD62L; EM cells have CD1271
CD62L phenotype, whereas CM cells should be CD1271CD62L1.
In peripheral lymphoid tissues, both CD81 T-cell memory subsets
may be found, but in the case of nonlymphoid tissues, EM CD81 T
cells are expected to be more prevalent due to the differences in
migratory pathways used [33]. Mechanisms of CD81 CTL survival
in mucosal tissues, in particular, in the small intestinal intra-
epithelial (SI-IEL) and lamina propria (SI-LP) are not well
understood yet [33–35]. Here, we addressed a role that IL-15 and
IL-7 play for the survival of memory IEL CD81 T cells in the SI in
mice that were mucosally vaccinated with modified vaccinia
ankara (MVA). We found that 2 months after MVA was intrarec-
tally (i.r.) administered, virus-specific B8R20–27/H2-K
b tetramer
(B8R tetramer)1 CD81 T cells were present in the SI-IEL.
Surprisingly, these cells in WT mice were mainly CD127CD62L,
in sharp contrast to the B8R tetramer1 CD81 T cells found in the
spleens of the same animals (EM and CM). Additionally, B8R20–27-
specific CTLs isolated from the SI-LP were CD127–CD62L– as well.
Moreover, such long-living CD127 CD81 T cells were found in
the SI-IEL isolated from IL-15 KO mice, indicating that some CD81
T-cell subpopulation is able to survive within the gut epithelial
layer in the absence of both IL-7 and IL-15 signaling. To find out
which surface markers could be associated with residual survival of
memory CD81 CTLs in the gut, cells from WT and IL-15 KO mice
were analyzed by flow cytometry for surface expression of CD11a,
CD11c, NKG2D, and CD8aa homodimer. We found that none of
these markers was expressed by the majority of the gut memory
CD81 CTLs.
Thus, we may conclude that the antigen-specific memory
CD81 CTLs residing in the SI-IEL compartment may be main-
tained for a long-term independently of signaling via IL-7 and
IL-15. Their survival may be dependent on soluble and/or cell
contact signals which substitute for cytokines specific predomi-
nantly for lymphoid tissues. Identifying these tissue-specific
prosurvival mechanisms may be crucial for the development of
new strategies for mucosal vaccination.
Results
Absence of IL-15 affects the antigen-specific CD81
T-cell response in mucosally vaccinated mice
In order to estimate quantitative and qualitative effect of IL-15 of
the antigen-specific CD81 T-cell response, WT and IL-15 KO mice
were i.r. inoculated with MVA. As a readout, we assessed MVA-
specific CTL expansion and contraction as well as their functional
activity during acute (day 5) and memory (2 months) phases
postinfection (p.i.), respectively. To enhance sensitivity of our
model, especially in IL-15 KO animals, we measured immune
response against the immunodominant vaccinia virus B8R20–27
epitope [36]. By flow cytometry, in WT mice during the acute
phase (5 days) of infection, a robust immune response was found,
with high relative percentages of B8R tetramer1 CD81 T cells in
the spleen as well as in the SI-IEL (Fig. 1 and Table 1). By day 13,
their frequencies both in the SI-IEL and spleen decreased
approximately two-fold compared with their level at day 5, and
contracted to as low as 1–2% by 2 months after immunization. In
sharp contrast, in IL-15 KO mice, the presence of B8R tetramer1
CD81 T cells was substantially lower compared with WT mice,
throughout the experiment (compare WT vs IL-15 KO: spleen, 5
days – 20.6271.12 vs 9.9772.03, p50.0101; 13 days –
10.7070.78 vs 1.4770.15, p50.0003; 2 months – 1.7370.12
vs 1.5370.09, p40.05; SI-IEL, 5 days – 23.8371.58 vs
3.3470.29, p5 0.0002; 13 days – 13.3970.68 vs 3.2070.75,
p50.0006; 2 months – 1.5970.17 vs 1.1970.36, p40.05).
Difference in kinetics between WT and IL-15 KO mice was more
evident when we estimated the absolute numbers of B8R
tetramer1 CD81 T cells in the spleen and the SI-IEL (Fig. 1;
compare WT vs IL-15 KO: spleen, 5 days – 1.4970.09 (106) vs
0.1570.03 ( 106), p50.0002; 13 days – 0.6470.03 ( 106) vs
0.1170.03 ( 106), p50.0003; 2 months – 0.0970.01( 106)
vs 0.0370.01(106), p50.0017; SI-IEL, 5 days –
1.7670.07( 106) vs 0.0870.02 ( 106), po0.0001; 13 days –
0.7770.04 ( 106) vs 0.1570.01(106), po0.0001; 2 months –
0.4370.02 ( 106) vs 0.0570.01( 106), p5 0.0001).
It is well known that IL-15 is a crucial cytokine necessary not
only for the survival of memory CD81 T cells, but also for their
functional activity. To ascertain functional avidity, we quanti-
tated IFN-g production by splenocytes and SI-IEL cells (by
ELISpot assay). We found that splenocytes from WT animals (Fig.
2A, upper panel; Fig. 2B and C show normalized and net IFN-g
response as percentage of max. and total response, respectively)
showed IFN-g production in response to titrated amounts of
B8R20–27 peptide. This response was at peak during acute phase
(5 days) after immunization, and declined with time. In contrast,
in IL-15 KO mice the magnitude of response to the highest dosage
of B8R20–27 peptide (1mM; characterizes total responders to
peptide epitope) was significantly lower (compare WT vs IL-15
KO: 5 days – 1358.677311.10 vs 430.007164.62, p50.0577).
Furthermore, the immune response in IL-15 KO mice decreased
with time more abruptly, as it was already markedly diminished
at 13 days after vaccination (WT vs IL-15 KO: 506.677116.09 vs
35.3375.24, p50.0072). Importantly, in IL-15 KO mice we
detected almost complete lack of CD81 T cells having high
functional avidity (recognizing 1 pM of B8R20–27 peptide), which
was already evident during the acute phase (compare WT vs
IL-15 KO: 5 days – 110.3376.06 vs 43.3375.81, p5 0.0624; 13
days – 61.3373.53 vs 21.0072.65, p50.0059; 2 months –
41.0072.31 vs 10.0070.58, p50.0002). Thus, IL-15 was found
to be important not only for the maintenance of antigen-specific
CD81 T cells during the memory phase (2 months p.i.), but also
for the generation of cells with full functional capacity (high
functional avidity).
In contrast to that which was found in the spleen, IFN-g
production in the SI-IEL compartment from the WT animals was
barely detectable 2 months after immunization (Fig. 2, lower
panel; compare 5 days vs 2 months 1 mM: 666.677370.33 vs
18.3373.18). Also, this response was characterized by skewing
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to the presence of cells recognizing high and middle concentra-
tions of B8R20–27 peptide (1mM and 100 pM) that further
distinguishes them from the splenic counterparts (compare
spleen vs SI-IEL, 5 days: 1 mM – 1358.677311.10 vs
666.677370.33; 100 pM – 506.677116.09 vs 421.337239.88;
1 pM – 41.0074.00 vs 0.9070.17). Strikingly, although B8R
tetramer1 CD81 T cells can be detected in SI-IEL in IL-15 KO
animals, these cells had almost completely lost capacity to
produce IFN-g even at the peak of infection (Fig. 2; compare 5
days vs 13 days: 1mM – 7.9074.55 vs 6.5373.31, p40.05).
Physical avidity and TCR expression disparate with
functional avidity of CTLs from intestinal tissues
Based on the ELISpot data, we reasoned that physical avidity of
TCR B8R tetramer1 CD81 T cells might affect their functional
capacity. To check this possibility, we assessed by flow cytometry
the level of TCR expression on B8R tetramer1 CD81 T cells
(Fig. 3A shows staining of naı¨ve splenoctes and SI-IEL cells and
Fig. 3B shows the strategy for gating cells as exemplified on WT
cells 5 days p.i.). We found that two uneven populations with
high and low TCR expression were present both in the spleen and
in the SI-IEL (Fig. 3C). Interestingly, during the acute and
memory phases, B8R tetramer1 CD81 T cells in the spleen from
both WT and IL-15 KO animals had comparable percentage of
cells with high TCR expression (WT vs IL-15 KO: 72 and 65% and
70 and 66%, respectively). In contrast, a different pattern was
found in the SI-IEL, whereas at the acute-phase CTLs in both
mouse strains highly expressed TCR at comparable, but still lower
frequency compared with the spleen (WT vs IL-15 KO: 55 and
50%, respectively); however, during the memory phase the cells
from WT but not IL-15 KO expressed the TCR at the same or even
higher level (WT vs IL-15 KO: 72 vs 32%, respectively). In fact,
among memory CTLs in the SI-IEL of the IL-15 KO animals, the
majority of B8R tetramer1 CD81 T cells expressed TCR at low
levels (compare day 5 vs 2 months: 49 vs 67%, respectively).
Thus, MVA-specific SI-IEL cells from the IL-15 KO mice but not
from WT animals had selective tissue-specific decline in the
frequency of B8R tetramer1 cells that expressed TCR at high
level, which was progressing from the acute to the memory
phase. The extensive and sustained TCR downregulation in the
absence of IL-15 may be linked to a higher activation status of
these cells and may be associated with a lower production of
IFN-g in IL-15KO animals. Additionally, by using B8R20–27/H-2K
b
tetramer, we measured mean fluorescence intensity (MFI) of
Figure 1. Kinetics of B8R20–27/H2-K
b tetramer1 CD81 T cells in the spleen and SI-IEL of C57BL/6 and IL-15 KO mice. (A) Relative percentages and
(B) absolute numbers of B8R tetramer1 CD81 T cells recovered from the spleen and SI-IEL of WT and IL-15 KO mice are presented. Lymphocytes
were isolated 5 days, 13 days, and 2 months after i.r. immunization with MVA 107 pfu/mouse. Cells were stained with PE-conjugated B8R20–27/H2-K
b
tetramer together with anti-CD8a (spleen) or anti-CD8b (SI-IEL) mAbs. Data shown are the mean1SD of three animals per group. Experiments were
performed twice with comparable results. Data were analyzed by unpaired Student’s t-test. po0.05, po0.01, po0.0001, ns: not significant.
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vaccinia virus-specific CTLs stained with different concentrations
of tetramer, which reflects the relative physical TCR avidity [37,
38]. For this, we isolated tissues from the WT animals 5 days after
i.r. infection with MVA. Comparison of the curves for CD81
T cells from the SI-IEL vs spleen (Fig. 4, left panel) revealed that
the MVA-specific CTLs expressed TCR with rather high physical
avidity for B8R20–27. Interestingly, the LP cells, which are
anatomically adjacent to the intraepithelial lymphocyte (IEL),
had slightly lower TCR avidity, but still it was much higher
compared with the spleen. Similar results were obtained when we
depicted the same data as a % of max. MFI level, determining an
average tetramer dilution factor giving 50% max. MFI (Fig. 4,
right panel): spleen – 1:60, SI-LP – 1:80, and SI-IEL – 1:200.
Altogether, we may conclude that data on functional and
physical avidity of MVA-specific CTLs isolated from spleen
(lymphoid tissue) correspond to each other, whereas in the SI-IEL
and SI-LP (nonlymphoid tissues) they do not. It may imply that
not only cell-intrinsic features (physical avidity) may shape CTL
functional activity, but cell-extrinsic parameters as well, espe-
cially in case of nonlymphoid tissues (cytokine milieu, costimu-
latory molecules). Our data on MFI of tetramer1 cells in IEL and
LP compared with spleen in the memory phase cannot answer
this question.
Memory antigen-specific CD81 T cells in SI-IEL and SI-
LP from IL-15 KO mice lack IL-7Ra/CD127 expression
It is known that both IL-7 and IL-15 are of crucial importance for
homeostatic proliferation of memory CD81 T cells [17, 24, 39]. In
particular, IL-15 signals are considered to be more important for
homeostatic proliferation of memory CD81 T cells, whereas IL-7
signals are responsible for their survival [31]. However, what
defines prosurvival conditions for memory CD81 T cells in different
nonlymphoid tissues, including the gut, is not well understood. At
least for the cells from the SI-LP, it was shown that they may
survive due to signals provided by nonhematopoietic cells via CD70
[40]. As was recently demonstrated by Jiang et al. [41], the
residual c-Myc-deficient CD8aa TCRab IEL cells display reduced
proliferation and increased apoptosis, which correlate with
significantly decreased expression of IL-15 receptor subunits and
lower levels of the antiapoptotic protein Bcl-2 [41]. Thus, c-Myc
controls the development of CD8aa TCRab IEL cells from thymic
precursors apparently by regulating IL-15 receptor expression and
consequently Bcl-2-dependent survival [41]. It is well accepted that
IEL lymphocytes are slower proliferating cells compared with other
lymphoid cells. In many experimental systems, IEL lymphocytes
alone did not show activation-induced proliferation, but they
Table 1. Phenotype of memory B8R20–27-specific CD8
1 T cells in the SI-IEL and spleen from WT and IL-15 KO micea)
Tissue Marker Time after infection
5 Days 2 Months
WT IL-15 KO WT IL-15 KO
SI-IEL CD1271CD62L 1.6270.16 2.2370.38 ND ND
CD1271CD62L1 ND 1.1770.64 ND 2.9371.13
CD11c1CD11a 1.1170.48 11.2770.71] 17.9071.99 12.7071.46
CD11c1CD11a1 7.9070.49 17.5071.04]] 3.3370.52 3.1270.19
CD11c–CD11a1 71.0073.51 37.6371.45 ND ND
NKG2D1 1.4070.21 8.4070.70 11.3770.45 10.4072.45
SI-LP CD1271CD62L 0.0770.07 0.0770.03 ND NEC
CD1271CD62L1 ND ND ND NEC
CD11c1CD11a 0.4770.15 NEC 14.7070.85 NEC
CD11c1CD11a1 24.6071.70 NEC ND NEC
CD11c–CD11a1 61.0072.08 NEC ND NEC
NKG2D1 0.3270.08 21.0071.91 20.7371.69 NEC
Spleen CD1271CD62L 1.7370.07 1.5370.05 73.3373.28 66.9073.77
CD1271CD62L1 2.2070.30 1.6370.08 15.0072.52 19.6771.45
CD11c1CD11a 6.5870.36 2.5670.59 1.0370.09 0.2370.15
CD11c1CD11a1 71.7773.26 67.4072.91 42.3372.03 43.2371.75
CD11cCD11a1 15.7370.94 16.0770.55 40.5371.81 42.7771.97
NKG2D1 70.9772.00 61.1373.21 80.3071.31 72.4373.35
a) Lymphocytes from WT and IL-15 KO animals were isolated at 5 days and 2 months after i.r. immunization with MVA 107 pfu/mouse. Four-color
flow cytometry was performed. Cells from tissues were stained with PE-conjugated B8R20-27/H2-K
b tetramer together with CD8a mAbs. Then,
cells were gated on tetramer1 CD81 T cells, and further analyzed for the expression of CD127, CD62L, CD11a, CD11c, and NKG2D markers
expression. Data shown are the mean percent of gated cells and SEM of three animals per interval and are one representative experiment of two
experiments performed with comparable results. ND, not detected; NEC, not enough cells: due to the paucity of the total isolated LP cells as well
as recovered B8R20–27/H2-K
b tetramer1 CTLs; ]p5 0.00057; ]]p5 0.00434; p5 0.00487; p5 0.00623. Text shaded in grey denotes the data with
significant differences in percentages of different surface markers between WT vs. IL-15 KO animals.
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significantly inhibited the proliferation of activated lymph node
T cells in a cell number-dependent manner [42].
To determine whether the cells from the SI-IEL comply to the
same prosurvival strategy, we first assessed by flow cytometry
whether the B8R tetramer1 CD81 T cells express CD127
(IL-7Ra). Memory CD81 T cells in the spleens in both mouse
strains developed toward EM (CD1271CD62L) and CM (CD1271
CD62L1) subsets at comparable frequencies (Fig. 5 and Table 1).
Surprisingly, however, very few memory B8R tetramer1 CD81
T cells from the SI-IEL both in WT and in IL-15 KO mice (Fig. 5
and Table 1) expressed CD127. The same was true for the gut cells
analyzed during the acute phase as well. In addition, SI-LP
lymphocytes from WT mice were also negative for CD127
expression during the entire experiment, and in IL-15 KO animals
it was proved at least at the acute phase (Fig. 5 and Table 1).
Thus, memory B8R-specific CD127lo/–CD81 T cells residing in the
SI-IEL compartment can be found not only in WT mice but also in
the IL-15 KO.
To evaluate whether residual IL-7Ra/CD1271 lymphocytes in
the SI-IEL were still able to transduce signals from IL-7, we
isolated SI-IEL lymphocytes, and treated them in vitro with
recombinant murine IL-7 cytokine (rmIL-7; 200ng/mL, 20min at
371C), followed by subsequent staining for intracellular phos-
phorylated STAT5 protein. As CTLs from naı¨ve and antigen-
experienced mice contain comparable low frequency of CD1271
cells (our unpublished data) and due to the paucity of antigen-
specific CD81 CTLs recoverable from SI-IEL compartment espe-
cially at the memory stage, we used SI-IEL cells from naı¨ve mice.
As a control, we used splenocytes. As shown in Fig. 6A and B, a
much smaller proportion of total SI-IEL lymphocytes was able to
mediate IL-7-dependent STAT5 phosphorylation compared with
total splenocytes (solid black and grey lines, respectively). The
relative percentage of IL-7Ra/CD1271 cells almost completely
corresponded to the frequency of IL-7-treated STAT5 (Y694)1
cells both in the SI-IEL (570.8 and 4.570.3, respectively) and in
the spleen (16.070.7 and 20.171.3, respectively). Thus, these
results confirm that the cells from the spleen as well as SI-IEL
express functional receptor for IL-7, but the proportion of TCRab1
CD8ab1 SI-IEL cells that express functional IL-7Ra/CD127 is
miniscule and much smaller than in the spleen (Fig. 6B).
Expression of CD11a, CD11c NKG2D, and CD8aa
homodimer on gut memory CD81 T cells requires IL-15
The prevalence during both acute and memory phases after
immunization of MVA-specific CTLs lacking IL-7 receptor in the
SI-IEL from both WT and even IL-15 KO animals suggested that
during the memory phase, SI-IEL lymphocytes might survive by
using alternative pathways without IL-7 or IL-15 signaling. Until
Figure 2. Functional avidity of B8R-specific CD81 T cells for IFN-g
production in the spleen and SI-IEL of C57BL/6 and IL-15 KO mice. (A–C)
Splenic (upper panels) and SI-IEL (lower panels) populations were
isolated from WT and IL-15 KO animals 5 days, 13 days, and 2 months
after infection, and treated with B8R20–27 peptide to perform ELISpot for
IFN-g production. B8R20–27 peptide (1 mM, 100 pM, and 1 pM) was added
directly to the tissue leukocyte populations, which were placed in
triplicates (Materials and methods). (A) Absolute numbers of responders/
106 total leucocytes to different peptide concentrations are shown. (B)
Normalized data calculated against the response to 1 mM of peptide are
shown. Dotted line corresponds to 50%max.response (max.respon-
se5 1 mM peptide concentration). (C) Percentage of responders out of
total response is shown [53]. Data are the mean1SD of three animals
per group. Experiments were performed twice with comparable results.
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recently, several attempts have been taken to phenotype memory
CD81 T cells in the SI-IEL in WT as well as TCR transgenic mice
[34, 43]. Based on these reports, we decided to study the
expression of plausible candidates (b2-integrins CD11a and
CD11c, and NKG2D) that could be associated with the gut
specific survival of memory CTLs.
At 5 days after immunization, B8R tetramer1 CD81 T cells in
the SI-IEL from WT and, to a lesser extent, in IL-15 KO animals,
abundantly expressed CD11a integrin (Fig. 7, upper panel;
Table 1), and a few of them were CD11a1CD11c1 (7.9070.49 vs
17.5071.04 for WT vs IL-15 KO, p5 0.00434; whereas the
majority were CD11a1CD11c–: 71.0073.51 vs 37.6371.45,
p50.00487). The same pattern was observed for the MVA-
specific CTLs from the LP (Table 1 and data not shown). In sharp
contrast, B8R tetramer1 CD81 T cells from the spleen in both
mouse strains revealed an inverse pattern of expression, where
the CD11a1CD11c1 subset was dominant, and CD11a1 CD11c
was subdominant. It is interesting that 2 months after immuni-
zation, the majority of B8R tetramer1 CD81 T cells in the SI-IEL
lost surface CD11a expression, and few of them were positive for
CD11c both in WT and in IL-15 KO mice (Fig. 7 and Table 1). In
contrast, in the spleen the vast majority of these cells
was expressing CD11a1 (>80%) being either single-positive
(CD11a1) or double-positive (CD11a1, CD11c1) (Table 1). Thus,
although at early stages both CD11a and CD11c may be induced
on the SI-IEL population, during the memory phase they were
downregulated irrespective of the presence or absence of IL-15 in
vivo, and thus these markers could not be associated with their
survival.
Apart from the b2-integrins, the NKG2D molecule is also
known to transduce costimulatory and/or prosurvival signals
after binding to a number of its ligands expressed by the gut
epithelial cells. At the acute stage, few B8R tetramer1 CD81
T cells in the SI-IEL and SI-LP from the WT mice expressed
NKG2D, whereas in IL-15 KO mice this frequency was modestly
increased (Fig. 8, upper panel; Table 1, compare WT vs IL-15 KO:
1.4070.21 vs 8.4070.70, p5 0.00623). In contrast, in the spleen
from both mouse strains, most antigen-specific CD81 T cells were
positive for NKG2D (Table 1), although in IL-15 KO mice their
frequency was slightly lower. When the cells were checked during
the memory phase, we saw that in all tissues (SI-IEL, spleen,
and SI-LP) from WT mice, especially in the gut, the relative
percentage of NKG2D1 tetramer1 CD81 T cells had increased
compared with the acute phase (Fig. 8, lower panel; Table 1) but
was still much smaller than that found in the spleen. In contrast,
in IL-15 KO animals, the percentage of NKG2D1 cells did not
change with time.
Along with that, previously it was shown that some of the
memory CTLs may express CD8aa homodimer, which may ligate
an MHC-class I-like molecule, thymus leukemia (TL) antigen,
known to be abundantly expressed on the basolateral membrane
of mouse intestinal epithelium [44, 45]. When we checked
appearance of CD8aa homodimer within the B8R tetramer1
CD81 T cells from the SI-IEL, we found that whereas 5 days after
infection SI-IEL cells expressed CD8aa homodimer in both mouse
Figure 3. TCR expression level on B8R-specific CTLs from SI-IEL and
spleen isolated during acute and memory phase after i.r. MVA-
immunization. Cells from WT and IL-15 KO mice were isolated during
acute and memory phases as described in the Materials and methods,
and stained with PE-conjugated B8R20–27/H2-K
b tetramer. Both splenic
and SI-IEL cells were costained with anti-CD8a and CD8b (spleen)
mAbs. Then, B8R tetramer1 CD8b1-gated CTLs were plotted against
CD8a. The level of B8R tetramer staining is shown. (A) The control
staining of lymphocytes from naı¨ve animals was performed and a very
low background was detected. (B) Originally, cells were gated on B8R
tetramer1 CD8b1 T cells as exemplified on WT cells, day 5 p.i. (C) TCR
level expression on B8R tetramer1 CTLs from spleen and SI-IEL is
shown on density plots and presented as percentage out of total B8R
tetramer1 CTLs. Data from a representative staining are shown.
Comparable results were found in three mice studied.
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strains (Fig. 9, upper panel), spleen cells did not express it at all.
Interestingly, the frequency of CD8aa homodimer-positive cells in
IL-15 KO mice was approximately three-fold higher compared
with WT animals. During the memory phase, no changes in
relative percentage of CD8aa1 cells were seen in either mouse
strains when compared with day 5, nor were positive cells found
in the spleens.
Thus, memory B8R tetramer1 CD81 T cells residing in the
SI-IEL compartment in both WT and IL-15 KO animals modestly
express CD127, CD11c, and NKG2D, but not CD11a. The relative
frequency of CD8aa homodimer-positive cells in the SI-IEL did
not change with time, and has mouse-strain-specific features. In
contrast, in both WT and IL-15 KO mice, the vast majority of
memory B8R tetramer1 CD81 T cells from the spleen expressed
CD11a and NKG2D, and some of them were positive for CD11c.
CD103 may also be involved in the maintenance of memory
cells at mucosal sites. However, a study by Masopust et al.
concluded that memory CTL from the IEL are positive for CCR9,
and less so for CD103 [46].
Altogether, the data obtained allow us to conclude that
although memory CTLs can be found in the SI-IEL, which factors
contribute to their survival in the absence of signaling via IL-7,
IL-15, CD11a and/or CD11c integrins, NKG2D, and CD8aa
homodimer remains unknown.
Discussion
The development of protective immunity is intrinsically
connected to the route of infection [46–50]. However, generation
and survival of antigen-specific CD81 T cells after i.r. immuniza-
tion is not well understood [10, 51, 52]. In this study, we
continued to characterize: (i) the kinetics of CD81 T-cell
responses in the gut after i.r. immunization, (2) the dependency
of functional activity and survival of antigen-specific CD81 T cells
from the SI-IEL compartment on IL-7 and IL-15 signals.
We found that the immune response in the spleen and SI-IEL
compartment from WT mice was characterized by induction of
B8R tetramer1 CD81 T cells that paralleled each other during
both expansion and contraction phases (Fig. 1). Response against
the immunodominant vaccinia virus B8R20–27 epitope (also
present in the MVA), may elicit as high as 12% total splenic CTLs
or up to 10106 vaccinia-virus-specific CTLs [36]. These data
perfectly fit to our results (Fig. 1). However, we saw that the
number of IFN-g-producing cells (Fig. 2) was much lower for the
SI-IEL compartment despite the substantial presence of B8R
tetramer1 CD81 T cells. As was shown here and in our recent
study [53], memory B8R20–27-specific CD8
1 T cells in the SI-IEL
compartment modestly produced IFN-g, but with low avidity,
whereas in the spleen they were characterized by populations with
low-, middle-, and high-functional avidity. In addition, B8R20–27-
specific CD81 T cells from the LP were previously shown to be
uniquely enriched in the high-avidity cells [53]. Thus, after
mucosal immunization, CD81 T cells with different functional
avidity were distributed unequally in different mucosal and
systemic sites. As shown in the current study, even greater changes
in functional activity were found in IL-15 KO mice, in which T cells
tended to quickly loose their IFN-g-producing capacity. Strikingly,
in the SI-IEL compartment from IL-15 KO animals even at the peak
of immune response a very modest response was detected (Fig. 2,
day 5).
As functional avidity may be directly linked to the physical
TCR avidity and high TCR expression level, we compared them
for B8R tetramer1 CTLs from the SI-IEL vs spleen. Interestingly,
we found that the modest functional activity of B8R20–27-specific
CD81 T cells from the WT SI-IELs did not correspond tightly to
the TCR expression level by the B8R tetramer1 CD81 T cells
(Fig. 3). In particular, although at the acute phase (day 5) the SI-
IEL from the WT mice had a pronounced in vitro IFN-g produc-
tion, however, only half of them were characterized by high TCR
level expression. In contrast, during the memory phase, although
they had hardly detectable functional activity, still the vast
majority of them expressed TCRs at high level that was even
increased compared with the acute phase. In sharp contrast,
although SI-IEL cells from the IL-15 KO animals had very low-
functional activity, the frequency of B8R tetramer1 CD81 T cells
with high TCR expression was comparable with that found in
the WT mice. Strikingly, during the memory-phase SI-IEL
Figure 4. Small intestinal B8R-specific IEL lymphocytes have high physical avidity for vaccinia virus B8R20–27 epitope. Cells from spleen (circles), SI-
IEL (squares), and SI-LP (triangles) were isolated from WT mice 5 days after i.r. immunization with 107 pfu MVA, and stained with anti-CD8b Abs
and B8R tetramer at the indicated dilutions. Left, mean fluorescence intensities (MFI) of CD8b1 T cells representative of three mice per tissue from
two comparable experiments are shown. Right, normalized MFI of CD8b1 T cells presented as a percentage out of max.MFI level.
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lymphocytes from IL-15 KO mice revealed an inverse proportion
of high-to-low TCR expression subsets, where the latter
comprised up to 67% compared with 27% for the WT mice.
However, due to the fact that the physical avidity of B8R tetramer
1 CTL in the SI-IEL was even higher compared with the spleen
(Fig. 4; WT mice), we may conclude that assessment of both
functional and physical avidities may be of special importance for
antigen-specific CD81 T cells residing in nonlymphoid tissues.
Altogether, IL-15 turned out to participate not only in expansion
of memory CD81 T-cell precursors (Fig. 1), but also in the
development of their full functional activity, which was evident
during the acute phase of infection (decreased number of total
and high-avidity responders). In particular, the lack of IL-15 in
vivo mostly affected functional activity/development of middle-
to-high avidity CD81 T cells and had less impact on low-avidity T
cells, consistent with our earlier finding that IL-15 promotes
induction of high-avidity CTLs [54].
A special role for IL-7 and IL-15 for survival and homeostatic
proliferation of memory CTLs has been documented in numerous
studies [18–23, 25, 35, 55, 56]. As we were able to detect
memory CTLs in the SI-IEL from the IL-15 KO animals, we deci-
ded to check if their survival was linked to CD127 expression and
IL-7 signaling. We showed by flow cytometry that during the
acute phase the vast majority of B8R tetramer1 CD81 T cells
isolated from SI-IEL both in the IL-15 KO and in the WT mice
were negative for CD127 expression (Fig. 5), consistent with the
data published elsewhere [34]. Additionally, we found that the
memory CTLs from LP were negative for CD127 as well (Fig. 5),
suggesting that some alternative prosurvival factor(s) specific to
the epithelial layer of the small intestine might exist. Such
Figure 5. Memory B8R tetramer1 CD81
T cells in SI-IEL from WT and IL-15 KO mice
express CD127 at low levels. Lymphocytes
from WT and IL-15 KO animals were
isolated at 5 days and 2 months after i.r.
immunization with MVA 107 pfu/mouse.
Four-color flow cytometry was performed.
Cells from IEL, LP, and spleen were stained
with PE-conjugated B8R tetramer together
with anti-CD8a mAbs. Then, cells were
gated on tetramer1 CD81 T cells, and
further analyzed for CD127 and CD62L
marker expression. Due to the paucity of
cells isolated from the LP of IL-15 KO mice
at 2 months p.i., these data are not
presented. One out of the two representa-
tive experiments is shown.
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assumption is substantiated by the finding that even in
naı¨ve C57BL/6 animals some nonspecific ‘‘memory-like’’ TCRb1
CD8ab1 T cells may be detected in the SI-IEL, which express
CD127/IL-7Ra at very low levels [57]. Here, we proved that
despite the low frequency of CD1271 SI-IEL cells, these few cells
were capable of transducing signals from IL-7 in vitro, thus
confirming the functionality of CD127/IL-7Ra on the gut CD8ab1
T cells from the IEL (Fig. 6). However, the vast majority of
memory CD81 T cells within intestinal epithelium were found to
survive independently of CD127 expression, thus ruling out IL-7
as a necessary survival factor in this tissue. In line with this,
previously it was shown that other cytokines, transducing signals
via the common gc-chain/CD132, may influence SI-IEL develop-
ment. In particular, the lack of signaling via IL-2, IL-4, IL-7, IL-9,
IL-15 affected only TCRab1CD8aa1 and TCRgd1CD8aa1 IEL
subsets [58–62], seemingly having no major impact on TCRab1
CD8ab1 IEL cells. On the other hand, selective overexpression of
either IL-7 [63] or IL-15 [64] by the gut epithelium did not result
in increased frequency of CD8ab1 T cells in the SI-IEL, possibly
because TCRab1 SI-IEL cells in naı¨ve mice express few if any
receptors for IL-2, IL-4, IL-7, IL-15 [65]. Similarly, splenic TCRab1
CD8ab1 T cells in naı¨ve mice do not entirely depend on the IL-15
signaling as they still contain CD44loCD122lo precursors of
‘‘conventional’’ TCRab1CD8ab1 T cells that were described in IL-
15 KO mice, thus, arguing for their IL-15-independent main-
tenance [66]. In fact, additional molecules might have had even
bigger impact on their prosurvival program (e.g. itk and IRF-1
etc.; [67, 68]). Based on this, we reasoned that in contrast to the
role for IL-7 and IL-15 documented in peripheral lymphoid
tissues, some other cytokine/cell-contact factors might be
involved in long-term maintenance of memory CD8ab1 T cells in
nonlymphoid tissues (intestinal epithelium; [69]). Although
some memory intraepithelial CD81 T cells can survive in the
small intestine in IL-15 KO mice after mucosal vaccination with
MVA, these mice will be significantly less protected against
mucosal challenge with WR virulent vaccinia virus compared
with WT mice. Some studies demonstrated already that IL-15
plays an important role in protection, especially in early activa-
tion of memory CD81 CTL after reinfection [70].
As was shown above, not only survival but also functional
activity of the gut memory CTLs was compromised in the IL-15 KO
mice. It is known that the local tissue microenvironment (cytokine,
chemokine, TLR–ligands, cell–cell contacts) can significantly influ-
ence the pathway of antigen presentation that elicits proliferation
and differentiation of CD81 T cells, affecting cytokine profile and
memory responses [71–76]. Inclusion of cytokines and other
biological adjuvants into vaccine formulas can facilitate skewing
immune responses both quantitatively and qualitatively in desirable
directions [3, 76]. As a result of such strategy, previously we found a
synergistic effect of cytokines and mucosal adjuvants for the
induction of mucosal and systemic CD81 T-cell responses together
with protective immunity against mucosal viral challenge [12, 50].
Moreover, such protection was mediated by CD81 T cells and was
associated with their presence at the mucosal site [77, 78]. Our
studies provided a better understanding of the effects that local
microenvironment (cytokines, cell contact signals) might have on
generation of memory CTL, particularly at mucosal sites. An
important factor for the development of effective memory CD81 T
cells is the presence of tissue-specific prosurvival factors. Our
current study demonstrated that the mechanisms of CTL survival in
mucosal tissues (small intestinal epithelium) may differ from those
present in peripheral lymphoid tissues.
As memory CTL which reside in the gut SI-IEL are nonmigrating
cells [46] and cannot recirculate with the pool of systemic memory
CTLs, they are unable to obtain prosurvival signals produced within
lymphoid tissues, e.g. IL-7 and IL-15. Thus, it is important to pin-
point what additional factors may contribute to their survival. Apart
from different signaling molecules involved in this process, it is also
plausible that the gut memory CTLs might merely depend on the
abundancy of nutrient factors supplied from food, in particular,
glucose. It is worth mentioning that in response to high-glucose
concentration some gut epithelial cell types are able to produce
IL-10 [79], that may also contribute to IEL-cell survival especially
when they are deprived of growth factors [80].
Figure 6. Residual CD127/IL-7Ra expression on naı¨ve CD81 T cells from
WT SI-IEL induces IL-7-specific STAT5 phosphorylation. Lymphocytes
from naı¨ve WT animals were isolated as described in the Materials and
methods. Then cells were either treated with recombinant murine IL-7
in DPBS/1%BSA (rmIL-7; 200 ng/mL, 20 min at 371C) or kept untreated.
(A) Histograms for intracellular phospho-STAT5 (Y694) expression on
total splenoctes and SI-IEL cells before and after adding rmIL-7
representative of two mice per tissue from two comparable experi-
ments are shown. (B) Relative percentages of IL-7-induced intracellular
STAT5 (Y694)1 total splenic and IEL populations from naı¨ve WT mice.
Isolated cells were treated in vitro with IL-7 (Materials and methods
section). Data show representative example from one out of the two
experiments. Error bars indicate mean1SD. Data were analyzed by
Mann–Whitney test, po0.0001.
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Despite the fact that currently no cytokine/cell contact
molecule(s) responsible for the survival of TCRab1CD8ab1
SI-IEL cells has been identified, still it is plausible to deduce that
somehow they may integrate signals which elicit constitutive
expression of antiapoptotic factors including cIAP-1, XIAP, bcl-xL,
and Mcl-1 as it was found in naı¨ve animals [81]. In fact, antigen-
specific memory TCRab1CD8ab1 from both spleen and SI-IEL do
express bcl-2 at high levels [34].
Besides classic surface markers that help to distinguish between
naı¨ve and memory CD81 T cells [31], little is known about the
expression of the activating NKG2D molecule on the CD81 T cells
in the SI-IEL. As a number of its ligands are expressed by the gut
epithelium, such ligation might be involved in providing prosur-
vival signals to the antigen-specific CTLs [82]. Previously, NKG2D
expression was described only on a subset of splenic memory
CD81 T cells [83], which transduces activating signals by
complexing with either DAP10, the only adaptor protein expressed
on CD81 T cells, and/or with DAP12 [83]. DAP10 under certain
circumstances is considered to transduce costimulatory signals in
CD81 T cells, whereas DAP12 has direct stimulatory activity in NK
Figure 7. Memory B8R tetramer1 CD81 T cells in the SI-IEL from WT and IL-15 KO mice express CD11a and CD11c at low levels. Lymphocytes from
WT and IL-15 KO animals were isolated at 5 days and 2 months after i.r. immunization with MVA 107 pfu/mouse. Four-color flow cytometry was
performed. Cells from IEL, LP, and spleen were stained with PE-conjugated B8R tetramer together with anti-CD8a mAbs. Then, cells were gated on
tetramer1 CD81 T cells, and further analyzed for CD11a and CD11c marker expression. Due to the paucity of isolated cells from the LP lymphocytes
of IL-15 KO mice at 5 days and 2 months p.i., these data are not presented. One out of the two representative experiments is shown.
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cells. CD81 T cells normally do not express DAP12; however,
during in vitro stimulation with IL-2, at least CD81CD44lo
T cells do express DAP12 [84]. Importantly, in naı¨ve mice neither
TCRab1 nor TCRgd1 SI-IEL cells express NKG2D, i.e. that only
cytokine-specific and/or antigen-specific activation may be
responsible for NKG2D expression [65, 83]. Thus, we speculated
that during antigen-specific stimulation, signaling via NKG2D in
CD81 SI-IEL cells might substitute for the lack of prosurvival IL-7
and IL-15. We found that the frequency of NKG2D1 cells was
increased in IEL (and LP) from IL-15 KO mice at memory phase
compared with acute phase (Fig. 8). We may suppose that at least,
in part, NKG2D expression may be associated with CTL survival
both in the SI-IEL and in the SI-LP compartments.
Additionally, we investigated the expression on B8R
tetramer1 CD81 T cells of CD8aa homodimer (Fig. 9), which
binds to the TL antigen, known to be abundantly expressed on
the basolateral membrane of mouse intestinal epithelium [45].
Due to the fact that the CD8aa homodimer was shown to be
transiently expressed on activated CTLs, we thought it might
contribute to the survival and differentiation of CD8 memory
Figure 8. Memory B8R tetramer1 CD81 T cells in SI-IEL from WT and IL-15 KO mice express NKG2D at low levels. Lymphocytes from WT and IL-15
KO animals were isolated at 5 days and 2 months after i.r. immunization with MVA 107 pfu/mouse. Triple-color flow cytometry was performed.
Cells from IEL, LP, and spleen were stained with PE-conjugated B8R tetramer together with anti-CD8b mAbs. Then, cells were gated on tetramer1
CD81 T cells, and further analyzed for NKG2D marker expression. Due to the paucity of isolated cells from the LP of IL-15 KO mice at 2 months p.i.,
these data are not presented. One out of the two representative experiments is shown.
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T-cell precursors. Although the interaction of CD8aa homodimer
with TL antigen may be of some importance in antigen-experi-
enced CTL, however, it was not involved in survival of nonspecific
CD8aa1 TCRab1 and CD8aa1 TCRgd1 IEL cells [85]. In our
study, we saw that during both acute and memory phases the
frequency of CD8aa1 B8R tetramer1 CTLs was increased only in
the SI-IEL from IL-15 KO but not from WT mice (Fig. 9).
Collectively, around 16 and 21% of total memory CTL in the SI-
IEL from WT and IL-15 KO mice were positive for either NKG2D
or CD8aa, which could bind to the gut epithelium-specific ligands
(Figs. 8 and 9). These results raise the possibility that somehow
memory CTL from SI-IEL compartments were shifting their
programs toward higher frequencies of NKG2D1 and CD8aa1
that might be associated with their survival in the absence of IL-7
and IL-15 signaling.
Altogether, our findings emphasize that the local tissue
environment in the intestinal mucosa is unique, and shapes and
organizes very specific populations of different protective
lymphocytes and allows CD81 T-cell survival without IL-7 or
IL-15 signaling. Furthermore, an environmental condition in the
intestinal epithelium does not promote IFN-g production by
SI-IEL cells long after vaccination, whereas in the adjacent LP
they are enriched with high avidity IFN-g-producing CD81 CTLs
[53]. What factors contribute to the development of prosurvival
conditions that facilitate the maintenance of antigen-specific
T cells in the gut mucosa and their unique pattern of functional
activity remains to be investigated.
Materials and methods
Mice
Female C57BL/6 mice were purchased from the Frederick
Cancer Research Center (Frederick, MD). IL-15 KO mice on
the H2-Kb C57BL/6 genetic background were purchased from
Jackson Laboratories.
Viruses and immunization protocol
MVA, developed by A. Mayr, University of Munich, Germany
[86], was propagated and titrated in chicken embryo fibroblast
cells. This virus was a gift of Dr. Bernard Moss, Dr. Patricia Earl,
and Dr. Linda Wyatt (NIAID). For immunization, mice were
injected i.r. with 107 pfu MVA as described previously [87].
Cell purification: Isolation of SI-IEL and LP lympho-
cytes, and lymphocytes from the spleen
Spleens were aseptically removed and single-cell suspensions
were prepared by gentle passage of the tissue through sterile
screens. SI-IEL cells and LP lymphocytes from mice were isolated
as described previously with a minor modification [52].
Flow cytometry
Flow cytometry was performed by using a FACScalibur, and data
were further analyzed with CellQuest software (BD Biosciences)
[88]. The following mAbs were used: FITC-conjugated anti-
CD62L (clone 53–5.8; obtained from BD Biosciences), Allophy-
cocyanin (APC)-conjugated anti-CD127 (clone A7R34); APC-
conjugated anti-NKG2D (clone CX5), APC-conjugated anti-CD8b
(clone CT-CD8b; all obtained from eBiosciences). Soluble
tetrameric B8R20–27/H2-K
b complex was conjugated to PE-
labeled streptavidin (made by the NIH Tetramer Core Facility).
Figure 9. Memory B8R tetramer1 CD81 T cells in SI-IEL from IL-15 KO
mice contain a higher frequency of CD8aa-homodimer1 cells than WT
mice. Splenocytes and SI-IEL cells from WT and IL-15 KO animals were
isolated at 5 days and 2 months after i.r. immunization with MVA
107 pfu/mouse. Triple-color flow cytometry was performed. Cells were
stained with PE-conjugated B8R tetramer together with anti-CD8a and
anti-CD8b mAbs. Then, cells were gated on tetramer1 CD81 T cells, and
further analyzed for the expression of CD8aa-homodimer. One out of
the two representative experiments is shown.
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IL-7 bioassay
Lymphocytes from naı¨ve WT animals were either treated with
recombinant murine IL-7 (rmIL-7; PeproTech) in DPBS/1% BSA
or kept untreated, and incubated for 20min at 371C. To verify
rmIL-7-specific signaling, cells were stained for intracellular
phosphorylated STAT5 protein with antiphospho STAT5 (Y694)
Alexa Fluors-488 mAbs according to the manufacturer (clone 47;
BDTM PhosFlow) and studied by flow cytometry. Additionally,
cells were stained with mAbs against APC-conjugated anti-CD127
(clone A7R34; eBiosciences).
IFN-c ELISpot
IFN-g ELISpot was performed as described previously [89]. Cells
were plated in triplicates in a volume of 200mL, 0.2 106/well, to
which we directly added titrated the amounts of B8R20–27 peptide
(TSYKFESV), which is an immunodominant poxvirus CTL epitope
restricted by H-2Kb [36]. Spots were counted in AID ELISpot
Reader (Cell Technology). Data are presented as the mean and
SEM of three animals per interval. These experiments were
performed twice with comparable results.
Statistical analysis
Statistical comparisons were assessed by unpaired Student’s t-test
and Mann–Whitney test by using GraphPad Prism version 5.00,
GraphPad Software (San Diego, CA; www.graphpad.com).
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